Obesity in early adulthood may be linked to an increased risk of multiple sclerosis (MS), a new study found.

Americans spent $30.2 billion on complementary health approaches in a year, according to a recent analysis.

Teva Pharmaceuticals has suspended sales, marketing and distribution for now for the Zecuity (sumatriptan iontophoretic transdermal system) patch.

Women who have been diagnosed with migraines may have a slightly raised risk of heart disease events and heart-related death, a new study found.

The US Food and Drug Administration has approved a new treatment for relapsing forms of multiple sclerosis.

Besides stress reduction, improved flexibility and exercise, yoga may provide another health benefit, a new study found.

Environmental toxins, such as certain pesticides, may be tied to an increased risk for a serious neurodegenerative disease, a new study found.

The US Food and Drug Administration (FDA) has approved a new opioid with abuse-deterrent properties.

The US Food and Drug Administration (FDA) has approved Nuplazid (pimavanserin) tablets to treat hallucinations and delusions in patients with Parkinson's disease.

Who wants to take medication twice a day when you can take it once a day?